SCHEMBL7744274

SCHEMBL7744274

N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCCCNC(=O)CC[C@H](N)C(=O)NCCCC[C@@H]2NC(=O)[C@@H](Cc3ccc4ccccc4c3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC2=O)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.52
NFE2L2 Q16236 1/20 0.52
CXCR4 P61073 3/20 0.51
ITGB3 P05106 4/20 0.49
ITGAV P06756 3/20 0.49
ITGB1 P05556 2/20 0.49
ITGA5 P08648 2/20 0.49
FURIN P09958 1/20 0.48
ITGB5 P18084 2/20 0.47
TSLP Q969D9 1/20 0.47
SIRT2 Q8IXJ6 4/20 0.46
SIRT1 Q96EB6 4/20 0.46
SIRT3 Q9NTG7 4/20 0.46
CTSG P08311 1/20 0.45
ITGA2B P08514 1/20 0.44
MC4R P32245 4/20 0.44
MC5R P33032 4/20 0.44
MC3R P41968 4/20 0.44
MC1R Q01726 4/20 0.44
PIN1 Q13526 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19981446 0.93 ITGB3 (0.56) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL22970321 0.93 ITGB3 (0.56) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7743670 0.93 ITGB3 (0.56) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7744260 0.93 ITGB3 (0.56) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL8365682 0.90 CXCR4 (0.49) KEAP1NFE2L2CXCR4ITGB3ITGAV
SCHEMBL7743576 0.87 SIRT2 (0.51) KEAP1NFE2L2CXCR4ITGB3ITGAV
SCHEMBL22738696 0.85 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGB1
SCHEMBL22872747 0.85 ITGB3 (0.51) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL23999259 0.85 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGB1
SCHEMBL14585807 0.84 ITGB3 (0.49) KEAP1NFE2L2ITGB3ITGAVITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6537520-B1 Diagnosis and treatment of cancer; kit containing compound having peptide or peptidomimetic functionality that binds to a alpha v beta 3 receptor linked to a chelator BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-03-25 US disclosed